EFTA01447217.txt Text dataset_10 View on DOJ

Illegal Activity

none

Blackmail

none

Date

2014-04-02

Document Type

financial_report

Model

gemini-2.0-flash-001

Processed

2026-02-07T18:41

Summary

This document is a financial report detailing an investment portfolio's performance as of April 2, 2014. It lists various biotech stocks, their quantities, prices, costs, market values, and unrealized gains/losses.

Metadata

Subject: Investment Portfolio
Sender: —
Recipients: —
Document ID: DB-SDNY-0101780
Date: 2014-04-02

Financial Information

Amounts:17.518.44875,500.00422,214.00453,286.00308.71119.55646,747.45250,454.95396,292.5031.6227.51790,500.00687,663.50102,836.5073.7979.41597,699.00643,204.00(45,505.00)3,043,139.832,294,533.85906,910.008.0317.60132,693.38290,997.40(158,304.03)

Assets:

SANGAMO BIOSCIENCES
BIOGEN
FOUNDATION MEDICINE
GILEAD SCIENCES INC
ARIAD PHARMACEUTICALS

Raw Analysis JSON click to expand

Themes

Financial transactions/money flow

Organizations 5

SANGAMO BIOSCIENCESBIOGENFOUNDATION MEDICINEGILEAD SCIENCES INCARIAD PHARMACEUTICALS

Text Analysis

Tone: Informative
Purpose: To provide a snapshot of an investment portfolio's performance as of a specific date.
Significance: Shows the holdings, quantities, prices, costs, market values, and unrealized gains/losses for various biotech stocks.

File Info

File Name: EFTA01447217.txt
Dataset: dataset_10
Type: Text
Model: gemini-2.0-flash-001
Processed: 2026-02-07T18:41:36.302011
DOJ Source: View on DOJ